Friday 6 November 2026 Export NAMS’s income statement to Excel — free account

NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Company N.V.’s revenue for fiscal 2025 (year ended December 2025) was $22.5 million, down 50.6% from fiscal 2024.

Revenue: +5,406.9%
EPS: +77.1%
Free cash flow: −21.8%

Quarter to September 2026, against a year earlier

Insider buying

19.17 0.28 +1.48%

Follow NAMS

Alert me

Market cap: $2.3B
P/E: 0.0×
Fwd P/E: −11.0×
Dividend yield: —
F-score: 3/9
Altman Z: 27.63
Beneish M: n/a
Dividend safety: n/a

Overview

NewAmsterdam Pharma Company N.V. (NAMS) P/E ratio

Alert me on P/E ratio

NewAmsterdam Pharma Company N.V. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 22.7× (September 2021) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/NAMS/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="NewAmsterdam Pharma Company N.V. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/NAMS/metrics/pe-ratio">NewAmsterdam Pharma Company N.V. (NAMS) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2022	8.1×	—

Period	P/E ratio	Change
Sep 2026	0.0×	—
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	0.0×	—
11 more quarters	Free account

Against its own ten years

Low 0.0× High 22.7×

Ten-year median 0.0×

Current reading's percentile 77

Company	P/E ratio
NAMS NewAmsterdam Pharma Company N.V.	n/m
PVLA Palvella Therapeutics, Inc. compare	n/m
PHVS Pharvaris N.V. compare	n/m
MBX MBX Biosciences, Inc. compare	n/m
RXRX Recursion Pharmaceuticals, Inc. compare	n/m
XNCR Xencor, Inc. compare	n/m
ZLAB Zai Lab Limited Unsponsored ADR compare	n/m
CLDX Celldex Therapeutics, Inc. compare	n/m
ADMA ADMA Biologics Inc compare	16.7×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

NewAmsterdam Pharma Company N.V. (NAMS) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on NAMS

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on NAMS

Stockrow Weekly